Biochemical Morbidity in Sleep Apnea

Coccagna C , Mantovani M. Tracheostomy in hypersomnia with periodic breathing. Bull Physiopathol Resp 1972; 8:1217–27.

Guilleminault C , Simmons FB , Motta J , Obstructive sleep apnea syndrome and tracheostomy: Long-term follow-up experience. Arch Inter Med 1981; 14:985–8.

Strohl KP , Cherniack NS , Gothe B. Physiological basis of therapy for sleep apnea. Am Rev Respir Dis 1986; 134:791–802.

Cahan C , Decker MJ , Arnold JL , Diurnal variations in serum erythropoietin levels in healthy subjects and sleep apnea patients. J Appl Physiol 1992; 72(6):2112–7.

Cahan C , Denko C , Arnold J , Insulin levels in sleep apnea syndromes. Chest 1990; 98:122s.

Cahan C , Arafah B , Decker MJ , Adrenal steroids in sleep apnea before and after NCPAP treatment. Am Rev Respir Dis 1991; 143:A382.

Modan M , Halkin H , Almog S , Hyperinsulinemia: a link between hypertension, obesity, and glucose intolerance. J Clin Invest 1985; 75:809–17.

Roberts CT , LeRoith D. Interactions in the insulin-like growth factor system. NIPS 1992; 69–75.

Ferannini E , Haffner SM , Mitchell BD , Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetalogia 1991; 34:416–22.

Ferrannini E , DeFrango RA . The association of hypertension, diabetes, and obesity: areview. J Nephrol 1989; 1:3–15.

Fletcher EC , DeBehnke RD , Lovoi MS , Undiagnosed sleep apnea in patients with essential hypertension. Ann of Int Med 1985; 103:190–5.

He J , Kryger MH , Zorick FJ , Mortality and apnea index in obstructive sleep apnea: Experience in 385 male patients. Chest 1988; 94(1):9–14.

Partinen M , Guilleminault C. Daytime sleepiness and vascular morbidity at seven-year follow-up in obstructive sleep apnea patients. Chest 1990; 97:27–32.

Landsberg L. Obesity, metabolism, and hypertension. Yale J of Bio & Med 1989; 62(5):511–19 (65 ref.).

Landsberg L , Krieger DR . Obesity, metabolism, and the sympathetic nervous system. Am J Hypertens 1989; 2:125S–132S (72 ref.).

Gerrner ME , Bersch N , Nakamoto JM , Use of in vitro clonogenic assays to differentiate acquired from genetic causes of insulin resistance. Diabetes 1991; 40:28–36.

Hoffstein V , Rubenstein I , Mateika S , Determinants of blood pressure in snorers. The Lancet 1988; (Oct. 29):992–4.

Waller PC , Bhopal RS . Is snoring a cause of vascular disease? An epidemiological review. The Lancet 1989; (Jan. 21):143–6.

Redline S , Tishler PV , Browner I , Risk factors for sleep apnea (SA) in a genetic-epidemiologic study: variation by age. Am Rev Respir Dis 1991; 145:A866.

Shepard JW Jr. , Cardiorespiratory changes in obstructive sleep apnea, in Kryger MH , Roth T , Dement WC (eds): Principles and Practice of Sleep Medicine. Philadelphia, W.B. Saunders Co., 1989; 543.

Young TB , Zaccaro DJ , Paulus K. Body habitus correlates of sleep=disordered breathing in a general population sample of 406 adults. Am Rev Respir Dis 1992; 145:A866.

Boudoulas H , Schmidt HS , Clark RW , Anthropometric characteristics, cardiac abnormalities and adrenergic activity in patients with primary disorders of sleep. Journal of Medicine 1983; 14(3):223–38.

Ozaki N , Okada T , Iwata T , Plasma norepinephrine in sleep apnea syndrome. Neuropsychobiology 1986; 16:88–92.

Krieger J , Laks L , Wilcox I. Atrial natriuretic peptide release during sleep in patients with obstructive sleep apnea before and during treatment with nasal continuous positive airway pressure. Clinical Science 1989; 77:407–11.

Krieger J , Schmidt M. Sforza E , Urinary excretion of guanosine 3′:5′-cyclic monophosphate during sleep in obstructive sleep apnea patients with and without nasal continuous positive airway pressure treatment. Clinical Science 1989; 76:31–7.

Follenius M , Krieger J , Krauth MO , Obstructive sleep apnea treatment: peripheral and central effects on plasma renin activity and aldosterone. Sleep 1991; 14(3):211–17.

Grunstein RR , Ho KY , Sullivan CE . Sleep apnea in acromegaly. Ann Int Med 1991; 115:527–32.

Cetel M , Facchini F , Skrobal A , Obstructive sleep apnea, insulin and glucose during nocturnal sleep with and without nasal CPAP. Am Rev Respir Dis 1992; 145:A169.

Grunfeld C , Baird K , Van Obberghen E , Glucocorticoid-induced insulin resistance in vitro: evidence for both receptor and post-receptor defects. Endocrinology 1981; 109:1723.

Katz I , Stradling J , Slutsky AS , Do patients with obstructive sleep apnea have thick necks? Am Rev Respir Dis 1990; 141:1228–31.

Czech MP , Mottola CM , Yu K-T , The insulin-like growth factor receptors, in Taiti S , Tolman RA (eds): Human Growth Hormone. New York, Plenum, 1986; 539–52.

Escouron P , Jirani A , Nedelcoux H , Systemic hypertension in sleep apnea syndrome. Chest 1990; 98:1362–5.

Sawada K , Krantz SB , Dessypris EN , Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development. J Clin Invest 1989; 83:1701–9.

Goldberg MA , Dunning SP , Bunn HF . Regulation of the erythropoietin gene: evidence that the oxygen sensor is a hema protein. Science 1988; 242:1412–15.

Goldberg MA , Glass AG , Cunningham JM , The regulated expression of erythropoietin by two human hepatoma cell lines. Proc Natl Acad Sci USA 1987; 83:7972–6.

Boehm KD , Kelley MF , Ilan J. Expression of insulin-like growth factors by the human placenta, in LeRoith D , Raizada MD (eds): Molecular and Cellular Biology of Insulin-Like Growth Factors and their Receptors. New York, Plenum, 1989; 179–93.

Engelmann GL , Boehm KD , Haskell JF , Insulin-like growth factors and neonatal cardiomyocyte development: ventricular gene expression and membrane receptor variations in normotensive and hypertensive rats. Molec Cell Endocrinol 1989; 63:1–14.

Van Wyk JJ , Somatomedins, in Li CH (ed): Hormonal Proteins and Peptides. New York, Academic, 1984; 81–125.

DeFronzo RA , Bonadonna RC , Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care 1992; 15:318–68 (445 references).